Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Core Scientific (CORZ) Invested Capital (2020 - 2026)

Core Scientific has reported Invested Capital over the past 7 years, most recently at -$220.7 million for Q1 2026.

  • Quarterly results put Invested Capital at -$220.7 million for Q1 2026, up 28.27% from a year ago — trailing twelve months through Mar 2026 was -$220.7 million (up 28.27% YoY), and the annual figure for FY2025 was -$962.7 million, down 2.27%.
  • Invested Capital reached -$220.7 million in Q1 2026 per CORZ's latest filing, up from -$962.7 million in the prior quarter.
  • Across five years, Invested Capital topped out at $1.2 billion in Q1 2022 and bottomed at -$1.3 billion in Q3 2025.
  • Median Invested Capital over the past 5 years was -$397.5 million (2023), compared with a mean of -$445.5 million.
  • The largest annual shift saw Invested Capital surged 912.69% in 2022 before it plummeted 348.5% in 2023.
  • Over 5 years, Invested Capital stood at -$409.3 million in 2022, then tumbled by 32.27% to -$541.4 million in 2023, then plummeted by 73.87% to -$941.4 million in 2024, then fell by 2.27% to -$962.7 million in 2025, then soared by 77.08% to -$220.7 million in 2026.
  • Business Quant data shows Invested Capital for CORZ at -$220.7 million in Q1 2026, -$962.7 million in Q4 2025, and -$1.3 billion in Q3 2025.